Dr. Jorge Maciel is a molecular microbiologist with 15+ years of research experience working in the areas of infectious diseases and immunology. Dr. Maciel currently leads the U.S. Army Edgewood Chemical Biological Center (ECBC) Biophysical Chemistry Branch affinity reagents team in developing new antibodies against various biological and chemical agents of interest, using his knowledge of biological threat agents and the scientific principles which limit the effectiveness of current biological detectors, samples, and assays to develop new countermeasures.

Dr. Maciel joined Excet, Inc. after completing of a National Research Council (NRC) Post-doctoral Research Fellowship with the BioDefense Branch, and was the recipient of a 2008 U.S. Army Seedling Initiative Program. In addition to his laboratory experience working with various biological agents, Dr. Maciel successfully developed a novel portable ricin activity detection substrate and assay. He was competitively awarded, and served as Principal Investigator for, a multi-year Defense Threat Reduction Agency program to utilize new molecular display technologies to identify and create novel thermostable ligands for biological agents of interest. In addition, Dr. Maciel has extensive experience in the evaluation of next-generation sequencing technologies and the use of resulting data sets for statistical identification and characterization of microorganisms in simple or complex sample matrices.

Dr. Maciel currently serves as both a Senior Research Scientist and as the Lead Supervisor for Excet, Inc. research scientists and support staff at ECBC. He received his B.S. from the University of  Notre Dame (South Bend, IN) and was awarded his Ph.D. in Molecular Microbiology and Immunology from Johns Hopkins University Bloomberg School of Public Health (Baltimore, MD).